-
1
المصدر: Advances in Therapy
مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Nivestim, medicine.medical_treatment, 0302 clinical medicine, Neoplasms, Secondary Prevention, Medicine, Pharmacology (medical), Longitudinal Studies, Prospective Studies, Original Research, Medicine(all), Cytotoxins, Biosimilar, General Medicine, Hematology, Middle Aged, Granulocyte-colony stimulating factor, Granulocyte colony-stimulating factor, Treatment Outcome, Tolerability, 030220 oncology & carcinogenesis, Female, medicine.drug, medicine.medical_specialty, Neutropenia, Filgrastim, Antineoplastic Agents, 03 medical and health sciences, Internal medicine, Hematologic Agents, Chemotherapy, Humans, Intensive care medicine, Biosimilar Pharmaceuticals, Aged, Febrile Neutropenia, Myelosuppressive Chemotherapy, business.industry, medicine.disease, 030104 developmental biology, Pre-Exposure Prophylaxis, business, Febrile neutropenia
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fccf9bbb4ad10e02843ef7514594c95a
http://europepmc.org/articles/PMC5083766